Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriflunomide concentrations in serum and cerebrospinal fluid in multiple sclerosis
2016-004414-10Phase 4Active
- Sponsor
- Sahlgrenska University Hospital
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of teriflunomide in multiple sclerosis (MS), sponsored by Sahlgrenska University Hospital. Primary endpoints: Serum teriflunomide concentration and Cerebrospinal fluid teriflunomide concentration. Started Jan 2018; status: active.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2016-004414-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004414-10.